Isaac Yang

Isaac Yang is a Professor of Neurosurgery at the University of California, Los Angeles (UCLA), where he specializes in neuro-oncology, skull base surgery, and brain tumor research. His clinical and translational work focuses on glioblastoma tumor biology, including the characterization of stem-cell-like states, genetic markers, and targetable biomarkers such as EMP2 in anti-angiogenic therapy resistance. His recent publications also explore radiation therapy complications, laser interstitial thermal therapy outcomes, and systematic reviews of rare spinal lesions. He directs research on superior canal dehiscence repair outcomes, incorporating frailty and sex-based analyses. Internationally, he collaborates with institutions across the US, Canada, Asia, and Europe, advancing surgical and oncological care.